卡培他滨
医学
来那替尼
肿瘤科
乳腺癌
内科学
转移性乳腺癌
癌症
曲妥珠单抗
结直肠癌
标识
DOI:10.1016/s1470-2045(19)30184-6
摘要
The results of a recent phase 2 trial have shown that combined treatment with neratinib and capecitabine is active in patients with refractory HER2-positive breast cancer who have brain metastases.
科研通智能强力驱动
Strongly Powered by AbleSci AI